Patterns of Intravenous Buprenorphine–Naloxone Misuse: Psychiatric Morbidity, Risk Behaviours, Diversion, and Serological Findings
Indian Journal of Psychological Medicine · 13.11.2026
DOI: 10.1177/02537176261503189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Psychological Medicine, online erschienen am 13.11.2026. Verfasst von Aaliya Khanam und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Mental Health and Neurosciences Kashmir, Government Medical College, Srinagar, Jammu and Kashmir, India. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Intravenous misuse of buprenorphine–naloxone (BPNX) is a growing concern for patients with opioid use disorder (OUD). However, data on psychiatric comorbidities, patterns of diversion, and the burden of infectious diseases among individuals who inject BPNX in India remain limited. This study aimed to assess the clinical profile, diversion patterns, and seroprevalence among these patients.
Methods
Seventy-three patients with a diagnosis of OUD injecting BPNX, were recruited for this study. Sociodemographic and clinical variables, diversion patterns, high-risk behaviors, and overdose history were assessed using a semi-structured proforma. Triple serology testing for HIV, HBV, and HCV was conducted, and relevant statistical analyses were performed.
Results
The participants were predominantly young men with a mean age of 25.9 ± 6.05 years. Psychiatric comorbidity was present in 67.1% of participants, and attention-deficit hyperactivity disorder (ADHD) was the most common diagnosis. HCV seropositivity was found in 68.5% and HCV RNA in 52.05%. Most participants used both prescription and diverted BPNX to avoid withdrawal symptoms. High-frequency misuse was significantly linked to longer opioid dependence and needle sharing.
Conclusions
The misuse of intravenous BPNX was linked to significant psychiatric comorbidity, unsafe injection practices, and a high burden of infectious diseases. The persistence of diversion despite the BPNX combination formulation suggests the current naloxone dose ratio may not be effective as a deterrent. Urgent integrated addiction, psychiatric, and harm-reduction services are needed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Mental Health and Neurosciences Kashmir, Government Medical College, Srinagar, Jammu and Kashmir, India.
- Nalanda Medical College and Hospital, Patna, Bihar, India.
- Government Medical College, Srinagar, Jammu and Kashmir, India.
ORCID-Profile: Aaliya Khanam, Rajnish Raj, Sunny Gidwani, Inaamul Haq, Zaid Ahmad Wani
Zitieren
APA
Khanam, A., Raj, R., Khare, V. K., Gidwani, S., Haq, I., Bhat, F. R., Wani, Z. A., Mehroosh, & Rather, Y. H. (2026). Patterns of Intravenous Buprenorphine–Naloxone Misuse: Psychiatric Morbidity, Risk Behaviours, Diversion, and Serological Findings. Indian Journal of Psychological Medicine. https://doi.org/10.1177/02537176261503189
Vancouver
Khanam A, Raj R, Khare VK, Gidwani S, Haq I, Bhat FR, et al. Patterns of Intravenous Buprenorphine–Naloxone Misuse: Psychiatric Morbidity, Risk Behaviours, Diversion, and Serological Findings. Indian Journal of Psychological Medicine. 2026. doi:10.1177/02537176261503189
BibTeX
@article{Khanam2026,
author = {Khanam, Aaliya and Raj, Rajnish and Khare, Vaibhav Kumar and Gidwani, Sunny and Haq, Inaamul and Bhat, Fazle Roub and Wani, Zaid Ahmad and Mehroosh and Rather, Yasir Hassan},
title = {Patterns of Intravenous Buprenorphine–Naloxone Misuse: Psychiatric Morbidity, Risk Behaviours, Diversion, and Serological Findings},
journal = {Indian Journal of Psychological Medicine},
year = {2026},
doi = {10.1177/02537176261503189}
}
EUVIMED